Articles From: Annual Energy Storage for Ancillary Services Capacity Installations Will Increase Ten-Fold by 2023, Forecasts Pike Research to Columbia Laboratories Reports Fourth Quarter and Year-End 2012 Financial Results


2013/3/14
Designed to respond to the technical challenges of generating, transmitting, and distributing electricity, ancillary services are required to balance the grid regardless of the structure of the electricity market.
Sign-up for Annual Energy Storage for Ancillary Services Capacity Installations Will Increase Ten-Fold by 2023, Forecasts Pike Research investment picks
2013/3/14
HOUSTON , March 14, 2013 /PRNewswire/ -- Quanta Services, Inc. (NYSE: PWR) today announced that Gerard Sonnier has joined the company as vice president and general counsel.
Sign-up for Quanta Services Names Gerard Sonnier General Counsel investment picks
2013/3/14
Exceeds guidance with record quarterly solar wafer and module shipments of 713 MW Exceeds guidance with record quarterly solar module shipments of 321 MW Exceeds guidance with quarterly revenues of US$306.5 million, up 40% quarter over quarter Achieves gross profit margin of 3.3% in the fourth quarter JIASHAN, China , March 14, 2013 /PRNewswire/ -- ReneSola Ltd ("ReneSola" or the "Company") (NYSE: SOL) , a leading global manufacturer of solar photovoltaic ("PV") modules and wafers, today announced its unaudited financial results for the fourth quarter and the full year ended December 31, 2012 .
Sign-up for ReneSola Ltd. Announces Fourth Quarter and Full Year 2012 Results investment picks
2013/3/14
MADISON, N.J. , March 14, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX) , the world's leading provider of diagnostic information services, today announced that Robert A.
Sign-up for Quest Diagnostics Announces Chief Financial Officer Transition Plan investment picks
2013/3/14
Announces Record Revenues and Adjusted EBITDA for Full Year 2012 HOUSTON , March 14, 2013 /PRNewswire/ -- GSE Holding, Inc. (the "Company" or "GSE") (NYSE: GSE) , a leading global provider of highly engineered geosynthetic containment solutions for environmental protection and confinement applications, today reported its financial results for the Company's fourth quarter and full year 2012.
Sign-up for GSE Reports Fourth Quarter and Full Year 2012 Results investment picks
2013/3/14
Transat A.T. Inc. - Results of First Quarter 2013 Canada NewsWire Improved Selling Prices Over Winter 2012 Revenues of $805.7 million , compared with $829.3 million in 2012.
Sign-up for Transat A.T. Inc. - Results of First Quarter 2013 investment picks
2013/3/14
BUFFALO, N.Y., March 14, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today reported financial results and development progress for the fourth quarter and fiscal year ended December 31, 2012.
Sign-up for Cleveland BioLabs Reports Fourth Quarter and Fiscal 2012 Financial Results and Development Progress investment picks
2013/3/14
TAMPA, Fla., March 14, 2013 (GLOBE NEWSWIRE) -- Health Insurance Innovations, Inc. ("HII" or the "Company") (Nasdaq:HIIQ) , today announced the purchase of its contract rights with TSG Agency, LLC.
Sign-up for Health Insurance Innovations, Inc., Announces Acquisition of Contract Rights From TSG Agency, LLC investment picks
2013/3/14
SANTA ANA, Calif.
Sign-up for Identive Selected as Contactless & Mobile Awards Finalist investment picks
2013/3/14
Broadwind Energy, Inc. (NASDAQ: BWEN) today announced a $35 million order for towers from a U.S. wind turbine manufacturer.
Sign-up for Broadwind Energy Wins $35 Million Tower Order investment picks
2013/3/14
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the signing of global license and supply agreements with Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) for the development and commercialization of Ligand’s Captisol-enabled ® , propylene glycol-free (PG-free) melphalan.
Sign-up for Ligand Signs Global License Agreement with Spectrum Pharmaceuticals for Captisol-Enabled® Melphalan investment picks
2013/3/14
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the Company has gained global development and commercialization rights to Ligand Pharmaceuticals’ (NASDAQ: LGND) Captisol-enabled ® , propylene glycol-free (PG-free) melphalan.
Sign-up for Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled® Melphalan investment picks
2013/3/14
TowerJazz , the global specialty foundry leader, today announced that its Israeli lender banks have extended its existing loans’ maturity dates, resulting in that 2013 and 2014 principal payments will be reduced from $105 million to $30 million.
Sign-up for TowerJazz’s Israeli Lender Banks Extend Its Loans’ Maturity Dates investment picks
2013/3/14
The Buckle, Inc. (NYSE: BKE) announced today that net income for the fiscal quarter ended February 2, 2013 was $61.4 million, or $1.29 per share ($1.28 per share on a diluted basis). Net income for the fiscal year February 2, 2013 was $164.3 million, or $3.47 per share ($3.44 per share on a diluted basis). Net sales for the 14-week fiscal quarter ended February 2, 2013 increased 7.0 percent to $360.6 million from net sales of $337.1 million for the prior year 13-week fiscal quarter ended January 28, 2012.
Sign-up for The Buckle, Inc. Reports Fourth Quarter and Fiscal Year 2012 Net Income investment picks
2013/3/14
Osiris Therapeutics, Inc. (NASDAQ: OSIR) , the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that C.
Sign-up for Osiris Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference investment picks
2013/3/14
New 25A, 50A and 70A IGBTs Designed for High Power, High Performance Industrial Applications ALISO VIEJO, Calif.
Sign-up for Microsemi Adds Multiple New Devices to Non-Punch Through (NPT) IGBT Product Family investment picks
2013/3/14
BioClinica ® , Inc., (NASDAQ: BIOC) , a global provider of clinical trial management services, announced today that JLL Partners and Ampersand Capital Partners, two leading middle market private equity firms, have completed their acquisition of BioClinica and CoreLab Partners and have combined the two companies under the name BioClinica.
Sign-up for BioClinica and CoreLab Partners Are One investment picks
2013/3/14
ORBCOMM Inc. (Nasdaq: ORBC) , a global satellite data communications company specializing in Machine-to-Machine (M2M) communications and solutions, today announced that it has entered into an agreement with System Planning Corporation to acquire substantially all of the assets of its GlobalTrak division.
Sign-up for ORBCOMM to Acquire GlobalTrak investment picks
2013/3/14
ORBCOMM Inc. (Nasdaq: ORBC) , a global satellite data communications company specializing in Machine-to-Machine (M2M) communications and solutions, today announced that it has entered into an agreement to acquire substantially all of the assets of MobileNet, Inc. (MobileNet), a leader of satellite and cellular-based telematics solutions for monitoring heavy equipment and assets that support the rail industry as well as being a long-time ORBCOMM value-added reseller.
Sign-up for ORBCOMM To Acquire MobileNet, Inc. investment picks
2013/3/14
PENNINGTON, N.J., March 14, 2013 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (Nasdaq:OPTT) ("OPT" or "the Company") today announced financial results for its fiscal 2013 third quarter and the nine months ended January 31, 2013.
Sign-up for Ocean Power Technologies Announces Results for the Fiscal Third Quarter Ended January 31, 2013 investment picks
2013/3/14
OAK BROOK, Ill.
Sign-up for Federal Signal Corporation Announces New Senior Secured Credit Facilities investment picks
2013/3/14
Lifetime Brands, Inc. (NasdaqGS: LCUT), a global provider of branded products used to prepare, serve and consume foods in the home, today reported its financial results for the fourth quarter and year ended December 31, 2012.
Sign-up for Lifetime Brands Reports 2012 Financial Results investment picks
2013/3/14
Agreement Provides Morgan Stanley with Greater Access to Emerging and Frontier Markets NEW YORK , March 14, 2013 /PRNewswire/ --   Auerbach Grayson & Company, LLC, a New York based brokerage firm specializing in global trade execution and exclusive in-depth research for U.S. institutional investors, announced today that it has sold a minority stake to Morgan Stanley (NYSE: MS) .
Sign-up for Auerbach Grayson Announces Minority Equity Investment from Morgan Stanley investment picks
2013/3/14
Covidien plc (NYSE: COV) will report second-quarter results on April 26, 2013, before trading begins.
Sign-up for Covidien plc to Report Second-Quarter Results on April 26, 2013 investment picks
2013/3/14
ArQule, Inc. (NASDAQ: ARQL) today announced its financial results for the year and for the fourth quarter ended December 31, 2012.
Sign-up for ArQule Reports Fiscal 2012 Year End and Fourth Quarter Results investment picks
2013/3/14
Lightspeed brings ARI's award-winning aftermarket PG&A solution to its more than 2,500 dealers MILWAUKEE , March 14, 2013 /PRNewswire/ -- ARI Network Services (OTCBB: ARIS) , a leader in creating, marketing, and supporting software, SaaS and DaaS solutions that connect consumers, dealers, distributors, and manufacturers in selected vertical markets, announced today that ADP Lightspeed of Salt Lake City, Utah and ARI have signed a multi‐year reseller agreement.
Sign-up for ARI and ADP Sign Reseller Agreement for ARI's AccessorySmart™ PG&A Solution investment picks
2013/3/14
Enphase Energy, Inc. (NASDAQ: ENPH) , today announced that the Enphase ® Microinverter System is available in Switzerland.
Sign-up for Enphase Energy Now Shipping in Switzerland investment picks
2013/3/14
Kirkland's, Inc. (NASDAQ: KIRK) today reported financial results for the 14-week and 53-week periods ended February 2, 2013.
Sign-up for Kirkland's Reports Fourth Quarter and Fiscal 2012 Results investment picks
2013/3/14
Columbia Laboratories, Inc. (Nasdaq: CBRX) today reported financial results for the three- and twelve-month periods ended December 31, 2012.
Sign-up for Columbia Laboratories Reports Fourth Quarter and Year-End 2012 Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Annual Energy Storage for Ancillary Services Capacity Installations Will Increase Ten-Fold by 2023, Forecasts Pike Research to Columbia Laboratories Reports Fourth Quarter and Year-End 2012 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity